HLY78

小分子

AKOS037643437 | SCHEMBL15995588 | 4-Ethyl-5-methyl-5,6-dihydro-[1,3]dioxolo[4,5-j]phenanthridine | A900672 | AC-36980 | 4-ethyl-5-methyl-8,9-methylenedioxy-5,6-dihydrophenanthridine | HLY78 | HLY-78 | 4-Ethyl-5-methyl-8,9-methylenedioxy-5,6-dihydrophenant

HLY78

H651654-5mg

5mg

≥98%

-20°C储存

超低温冰袋运输

HLY78, a Lycorine derivative, is a potent activator of the Wnt/β-catenin signaling pathway. HLY78 targets the DIX domain of Axin and promotes the Axin-LRP6 (lipoprotein receptor-related protein 6) association, thus promoting LRP6 phosphorylation and Wnt signal transduction. HLY78 can be used for subarachnoid hemorrhage (SAH) research In Vitro HLY78 inhibits apoptosis in tumor cells and embryonic cells caused by carbon ion radiation through activation of the Wnt/β-catenin pathway. HLY78 (20 μM, 0-48 h) significantly increases the colony formation ability by 2.78-fold and 2.88-fold for HGC-27 and AGS cells compared with the controls. HLY78 (20 μM, 0-48 h) elevates the migration ability of HGC-27 and AGS cells. HLY78 significantly increases TNKS expression, which is ameliorated by Dihydroartemisinin . MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo HLY78 (0-1.8 mg/kg, Intranasal injection, once) attenuates neuronal apoptosis and improves neurological deficits through the LRP6/GSK3β/β-catenin signaling pathway after SAH (subarachnoid hemorrhage) in rats. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Adult male Sprague-Dawley rats (280-310 g, n=9/group, SAH model)Dosage: 0, 0.2, 0.6, and 1.8 mg/kg Administration: Intranasal injection, once, at 1 h post-SAH (subarachnoid hemorrhage) Result: Significantly attenuated the short-term and long-term neurobehavioral deficits, as well as the neuronal apoptosis after SAH at 0.6 mg/kg. Successfully delivered into the brain via intranasal administration at 0.6 mg/kg and was sufficient to significantly increase the phosphorylation of LRP6. Reversed the changes of the Bcl-2, Bax, and cleaved caspase 3 levels. Form:Solid IC50& Target:Wnt/β-catenin

HLY78是一种Lycorine（HY-N0288）衍生物，是Wnt/β-catenin信号通路的强效激活剂。HLY78 靶向 Axin 的 DIX 结构域，促进 Axin-LRP6（脂蛋白受体相关蛋白 6）结合，从而促进 LRP6 磷酸化。

854847-61-3

C17H17NO2

267.32 g/mol

44422459

CCC1=C2C(=CC=C1)C3=CC4=C(C=C3CN2C)OCO4

4-ethyl-5-methyl-6H-[1,3]dioxolo[4,5-j]phenanthridine

1S/C17H17NO2/c1-3-11-5-4-6-13-14-8-16-15(19-10-20-16)7-12(14)9-18(2)17(11)13/h4-8H,3,9-10H2,1-2H3

FAZZYPIBZBGQSH-UHFFFAOYSA-N

CCC1=C2C(=CC=C1)C3=CC4=C(C=C3CN2C)OCO4

44422459

DMSO : 26 mg/mL (97.26 mM; Need ultrasonic)

0

3

1

267.126 Da

267.126 Da

21.700 Ų

20

0

361

0

1

3.9

UN30779/PGIII